Cindy Schultz, PhD
Owner, Monarch Medical Writing
Owner, Monarch Medical Writing
|
Academic/Clinical Experience
Cindy received her master’s degree in Human Genetics and her PhD in Microbiology and Immunology from the University of Michigan. She continued to conduct research in the area of molecular immunology as a Postdoctoral Fellow at DNAX Research Institute in Palo Alto, CA, and as a Research Scientist at Regeneron Pharmaceuticals in Tarrytown, NY. She then turned to clinical medicine, where she spent more than 8 years developing a busy clinical laboratory specializing in immuno- phenotyping, genetic testing, and cancer diagnosis at Montefiore Medical Center, the University Hospital for the Albert Einstein College of Medicine.
|
Med Ed Agency Experience
In 2002, Cindy joined the medical education company AlphaMedica, where she worked to develop educational programs related to: contrast-enhanced multidetector CT and MRI of the CNS, heart, breast, abdomen, and vasculature, as well as safety issues related to contrast use in diagnostic and interventional radiology; diagnosis, treatment, and management of open-angle glaucoma; use of botulinum neurotoxin in the treatment of spasticity, cervical dystonia, blepharospasm, and hyperhidrosis; diagnosis of acute ischemic stroke; diagnosis, treatment, and management of asthma and COPD; management of Gram-positive infections; and treatment of chronic hepatitis C.
|
Pharma Industry Experience
In 2007, Cindy left AlphaMedica to join Bracco Diagnostics Inc. as an Associate Director in the Global Medical and Regulatory Affairs Department. During her 8 years with Bracco, Cindy managed a large number of complex medical communication projects, both promotional and educational, related to the use of contrast for MRI, CT, ultrasound, and nuclear medicine.
Freelance ExperienceIn 2015, Cindy formed the freelance medical writing company, Monarch Medical Writing. Since then, in addition to the areas above, she has gained additional experience in the clinical areas of oncology (including immunotherapy and geriatric oncology), epilepsy (and related seizure disorders), and multiple sclerosis.
|